Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority Nod

Susmita Roy3 Sept 2025 1:43 PM IST

New Delhi: The Ministry of Health and Family Welfare has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019 that would allow...

Sun Pharma Asked to Resubmit Revised Phase III Protocol for Delafloxacin CABP Trial

Sun Pharma Gets CDSCO Panel Nod to Manufacture, Market Enzalutamide for Prostate Cancer

Susmita Roy3 Sept 2025 1:20 PM IST

New Delhi: The pharmaceutical major Sun Pharmaceutical Industries has received approval from the Subject Expert Committee (SEC), functional under the...

NPPA Fixes Retail Prices of 42 Formulations Including Amoxycillin, Dapagliflozin, Cefixime

Susmita Roy3 Sept 2025 10:11 AM IST

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, has...

Rajasthan Medical Services Corp Bans 7 Pharma Firms, 40 Drugs Over Quality Concerns

Health Ministry Drafts Rule Change to Halve Drug Trial Approval Time from 90 to 45 Days

Susmita Roy2 Sept 2025 9:15 PM IST

New Delhi: With an aim to ease the processes for preclinical and analytical drug testing, the Ministry of Health and Family Welfare has released draft...

Lupin secures SBTi validation for emission reduction targets

Lupin Gets Expert Committee Nod To Conduct Phase I Trial of Certolizumab Pegol, IGRA TB Test Made Mandatory

Susmita Roy1 Sept 2025 4:23 PM IST

New Delhi: Lupin has got approval from the Subject Expert Committee (SEC), under the Central Drugs Standard Control Organisation (CDSCO), to conduct a...

After Cough Syrup Deaths, IPC Issues Toolkit to Curb DEG, EG Contamination in Liquid Formulations

CDSCO Panel Allows Ravenbhel to Conduct BE, Phase III Trial of Dapagliflozin, Sacubitril, Valsartan FDC

Susmita Roy1 Sept 2025 1:52 PM IST

New Delhi: Ravenbhel Healthcare has got the go-ahead from the Subject Expert Committee (SEC), functional under the Central Drugs Standard Control...

B.Pharm Holders Not Eligible for Pharmacist Posts: Uttarakhand HC

Susmita Roy31 Aug 2025 4:00 PM IST

New Delhi: Citing lack of merit in their arguments, the Uttarakhand High Court has dismissed a batch of petitions filed by Bachelor of Pharmacy...

No Entrance Test Needed: UP Govt Approves Direct B.Pharm, D.Pharm Admission for 2025-26

B.Pharm Students' Certificates Withheld: Telangana HRC Pulls Up Nalgonda Pharmacy College

Susmita Roy31 Aug 2025 2:00 PM IST

New Delhi: The Telangana Human Rights Commission (TGHRC) has stepped in after nine B.Pharmacy (B.pharm, B.pharma) students from Venkateshwara...

Ropanicant Phase-2b trial for Major Depressive Disorder achieves 100 percent enrollment ahead of schedule: Suven Life Sciences

One Death a Day: 1,705 Lives Lost in India's Clinical Trials Since 2021, RTI Reveals

Susmita Roy31 Aug 2025 2:00 PM IST

New Delhi: In a grim reality, from 2021 till July 2025, clinical trials in India have seen 1,705 deaths and more than 7,000 serious adverse events,...

AstraZeneca Pharma India wins CDSCO permission to import breast cancer drug Datverzo

AstraZeneca Faces Setback as CDSCO Panel Rejects Seloken XL Prescribing Update

Susmita Roy31 Aug 2025 1:00 PM IST

New Delhi: Rejecting the proposal of AstraZeneca Pharma for the update of prescribing information (PI) of Metoprolol Succinate Prolonged Release...

PCI Allows One-Year Provisional Registration for D.Pharm Students Amid Exit Exam Delay

Pharmacy Institutions Failing to Submit Data by Aug 31 to Lose 2025-26 Approval: PCI

Susmita Roy30 Aug 2025 9:00 PM IST

New Delhi: The Pharmacy Council of India (PCI) has issued a final reminder to pharmacy institutions seeking approval under Section 12 for the 2025-26...

Mankind Pharma Wins PETKIND Trademark Battle, Court Orders Journal Advertisement Within Two Months

Susmita Roy30 Aug 2025 2:00 PM IST

New Delhi: In a major relief to Mankind Pharma Limited, the Delhi High Court has allowed the company's appeal challenging the rejection of its...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok